A. Velasco

VENO-OCCLUSIVE DISEASE OF THE LIVER ASSOCIATED WITH THIOPURINES IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA

J. M. Merino, F. Sáez‐royuela, F. Casanova, 2000, Pediatric hematology and oncology.

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study

V. Jiménez‐Yuste, P. Llamas, J. Martínez-López, 2020, Journal of Hematology & Oncology.

Real-World Outcomes of Belantamab Mafodotin for Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results of a Spanish Expanded Access Program (EAP)

E. Askari, I. Krsnik, J. Martínez-López, 2022, Oncology and Therapy.

Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study

J. Díez-Martín, L. Núñez, A. Jiménez-Ubieto, 2021, HemaSphere.

[Pseudothrombocytopenia: incidence, causes and methods of detection].

J. Merino, A. Velasco, M. Rodríguez, 1991, Sangre.

Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

E. Askari, J. de la Rubia, A. Garcia de Coca, 2022, Blood.

Compassionate Use of Belantamab Mafodotin for Treatment of Patients with Relapsed/Refractory Multiple Myeloma Heavily Treated. Spanish Experience

E. Askari, I. Krsnik, J. Martínez-López, 2021, Blood.